·|ij·§n
®i¾P«e¸m·|
¦aÂI
°Ñ®i/ÃÙ§U
¤j·|ijµ{
¸ß°Ý
³ø¦W
´CÅé¹Ù¦ñ
Insight Pharma Reports²£·~/¥«³õ±¡³ø¸ê®Æ
¤j·|ijµ{
3¤ë25¤é
3¤ë26¤é
3¤ë27¤é
3¤ë28¤é
¥DnºtÁ¿
Diagnosing the Disease
8:00 am - 9:45 am
Risk Diagnosis for Disease Prevention
8:00 am - 8:55 am
Disruption of the Pharmaceutical Industry
8:55 am - 9:40 am
Ice Bound - A Doctor's Incredible Battle for Survival at the South Pole
3:20 pm - 4:00 pm
®i¾P«e¸m·|
¥Íª«¬ì§ÞÃÄ«~¦X§@®i¾P·|
10:15 am - 5:30 pm
µu´Á¬ã°Q·|
¤W¤È
BIOMARKERS ARE US
10:15 am - 1:15 pm
THE CHALLENGE OF THE BLOOD-BRAIN BARRIER
ADMET CASE STUDIES FROM A MEDICINAL CHEMISTRY PERSPECTIVE
THE EPIGENETICS STEM CELL SIGNATURE
IMMUNOLOGICAL BIOMARKERS
µu´Á¬ã°Q·|
¤U¤È
CIRCULATING TUMOR CELLS
2:30 pm - 5:30 pm
CANCER STEM CELLS
MODELS FOR EVALUATING DRUG-DRUG INTERACTION POTENTIAL IN PRECLINICAL DEVELOPMENT
TO BE DETERMINED
Navigating Through Indian Regulatory Terra Incognita
·|ij
¤À¤l¶EÂ_
8:00 am - 6:00 pm
8:25 am - 5:45 pm
8:30 am - 3:05 pm
ÂåÃĤƾǪº¾Ç²ß
¸g¸ô¸ÑªR
·F²ÓM·|ij
°§C¬ã¨s¶}µo¤§·ÀI©M»ùȳХX¾Ô²¤
8:25 am - 5:45 pm
¨È¬wªvÀø¹êÅç
8:30 am - 3:05 pm
Á{§É«e¶}µo
ÂàĶÂåÀø
§K¬Ì¦]¤l(cytokine)Àøªk
Àùªº¤À¤l¼Ð¹v
薬¾¯¦w¥þ©Ê°Ê¦V
¤¤¤å©x¤èºô¯¸Àç¹B
CHI¥N²z°Ó ¤é°ÓÀô²y°T®§¦³¤½¥q